rdf:type |
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0079083,
umls-concept:C0144576,
umls-concept:C0205179,
umls-concept:C0246415,
umls-concept:C0278802,
umls-concept:C0282460,
umls-concept:C1512288,
umls-concept:C1556094,
umls-concept:C2603343
|
pubmed:issue |
3
|
pubmed:dateCreated |
2011-2-23
|
pubmed:abstractText |
The purpose of this study is to assess the efficacy and safety of treatment with taxane plus platinum in combination therapies for advanced or recurrent endometrial carcinoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1569-8041
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
636-42
|
pubmed:meshHeading |
pubmed-meshheading:20696677-Adult,
pubmed-meshheading:20696677-Aged,
pubmed-meshheading:20696677-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20696677-Carboplatin,
pubmed-meshheading:20696677-Carcinoma,
pubmed-meshheading:20696677-Cisplatin,
pubmed-meshheading:20696677-Endometrial Neoplasms,
pubmed-meshheading:20696677-Female,
pubmed-meshheading:20696677-Humans,
pubmed-meshheading:20696677-Kaplan-Meier Estimate,
pubmed-meshheading:20696677-Middle Aged,
pubmed-meshheading:20696677-Neoplasm Recurrence, Local,
pubmed-meshheading:20696677-Neoplasm Staging,
pubmed-meshheading:20696677-Paclitaxel,
pubmed-meshheading:20696677-Taxoids,
pubmed-meshheading:20696677-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|